Mizushina Yoshiyuki, Kasai Nobuyuki, Miura Katsumi, Hanashima Shinya, Takemura Masaharu, Yoshida Hiromi, Sugawara Fumio, Sakaguchi Kengo
Laboratory of Food and Nutritional Sciences, Department of Nutritional Science, and High Technology Research Center, Kobe-Gakuin University, Nishi-ku, Kobe, Hyogo 651-2180, Japan.
Biochemistry. 2004 Aug 24;43(33):10669-77. doi: 10.1021/bi049307r.
We reported previously that lithocholic acid (LCA, 3-alpha-hydroxy-5-beta-cholan-24-oic acid), one of the major compounds in the secondary bile acids, selectively inhibited the activity of mammalian DNA polymerase beta (pol beta) [Mizushina, Y., Ohkubo, T., Sugawara, F., and Sakaguchi, K. (2000) Biochemistry 39, 12606-12613]. The purpose of this study was to investigate the molecular structural relationship of LCA and its 10 chemically synthesized derivatives. The inhibitory activities of pol beta by some derivative compounds were stronger than that by LCA, and these compounds bound tightly to the 8-kDa domain fragment but not to the 31-kDa domain fragment of pol beta. Biacore analysis demonstrated that the 8-kDa domain bound selectively to compound 9 (3-alpha-O-lauroyl-5-beta-cholan-24-oic acid), which was the strongest pol beta inhibitor tested, as a 1:1 complex with a dissociation constant (K(d)) of 1.73 nM. From computer modeling analysis (i.e., molecular dynamics analysis), the 8-kDa domain had two inhibitor binding areas. Three amino acid residues (Lys60, Leu77, and Thr79) of the 8-kDa domain bound to LCA and compound 2 (3-alpha-methoxy-5-beta-cholan-24-oic acid), and four amino acid residues (Leu11, Lys35, His51, and Thr79) of the 8-kDa domain bound to compound 9. From these results, the structure-function relationship among pol beta and its selective inhibitors was discussed.
我们之前报道过,石胆酸(LCA,3-α-羟基-5-β-胆烷-24-酸)是次级胆汁酸中的主要化合物之一,可选择性抑制哺乳动物DNA聚合酶β(polβ)的活性[水岛洋、大久保彻、菅原芳树和坂口健(2000年)《生物化学》39卷,第12606 - 12613页]。本研究的目的是探究LCA及其10种化学合成衍生物的分子结构关系。一些衍生物化合物对polβ的抑制活性比LCA更强,并且这些化合物与polβ的8 kDa结构域片段紧密结合,但不与31 kDa结构域片段结合。生物传感器分析表明,8 kDa结构域与化合物9(3-α-O-月桂酰-5-β-胆烷-24-酸)选择性结合,化合物9是所测试的最强的polβ抑制剂,形成1:1复合物,解离常数(K(d))为1.73 nM。通过计算机模拟分析(即分子动力学分析),8 kDa结构域有两个抑制剂结合区域。该8 kDa结构域的三个氨基酸残基(Lys60、Leu77和Thr79)与LCA和化合物2(3-α-甲氧基-5-β-胆烷-24-酸)结合,8 kDa结构域的四个氨基酸残基(Leu11、Lys35、His51和Thr79)与化合物9结合。基于这些结果,讨论了polβ与其选择性抑制剂之间的结构-功能关系。